Adrien Mouren, MD

Medical Oncologist @gustaveroussy 🏥 | Drug Development & Skin Cancer 🩺 | Passionate about Precision Medicine 🧬 | Travel & Language Lover 🌍 | Movie Buff 🎬

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

Hear ye hear ye!
Targeting NRg1 fusions 🎯🎯🔥💡
🎯🎯FDA grants accelerated approval to zenocutuzumab-zbco for non-small cell lung cancer and pancreatic adenocarcinoma | FDA https://t.co/dUByGDcgW8

[Adrien Mouren, MD @AMourenMD]

Incredible insights today from @y_loriot on the Unlock program, delving into resistance mechanisms of new anticancer drugs, and @VibertJulien on Meditwin, virtual cancer avatars, both from @GustaveRoussy #DITEP department! Pushing boundaries in cancer research #PrecisionMedicine

[Adrien Mouren, MD @AMourenMD]

@VivekSubbiah @GustaveRoussy @ArBayle @PrismCenter @oncodaily @OncoAlert @amalsargsyan @PARISImd @IshwariaMD @PTarantinoMD Thanks again for your time and for the inspiring conversation! Grateful for the unique opportunity to learn from you. Looking forward to more inspiring moments ahead!

[Vivek Subbiah, MD @VivekSubbiah]

⭐️Future of early-phase drug development & #PrecisionMedicine is bright @GustaveRoussy ! Such a delight to meet with amazing colleagues @ArBayle @AMourenMD @PrismCenter IHU kickoff event & discuss latest & greatest in drug development @oncodaily @OncoAlert ! Thank you for all your insightful questions

[Adrien Mouren, MD @AMourenMD]

Feeling inspired after @VivekSubbiah’s insightful talk on precision medicine @ the kick-off meeting for @PrismCenter in @UnivParisSaclay @GustaveRoussy His visionary approach is a model for us all in advancing cancer care through patient-centric clinical trials #PrecisionMedicine

[Gustave Roussy @GustaveRoussy]

📢 @GustaveRoussy célèbre la #RechercheClinique du 20 au 26 mai 2024 !

Cette année, un webinaire sur ✨Le système immunitaire pour soigner le cancer✨ se déroulera le jeudi 23/05 à 18h.

Plus d'informations à venir ⌛

[AACR @AACR]

Skin cancer is the most common cancer in the U.S. Learn about prevention, screening, and treatment of skin cancer during #melanoma and #skincancer awareness month: https://t.co/QCTg1IaPeX

[ESMO - Eur. Oncology @myESMO]

New 📢 #MerkelCellCarcinoma: ESMO–@ERN_EURACAN Clinical Practice Guideline for diagnosis, treatment & follow-up. Algorithms also provided. MDT w/ high level of expertise should diagnose & make tx decisions. https://t.co/xC8bkdeIjo @ILugowska @PAscierto @rutkowskip1972 @AlfredoBerruti @ESMO_Open #ESMOGuidelines

[Cancer Discovery @CD_AACR]

Read a Special Commentary from the April issue—
#Somatic Mutations in Normal Tissues: Calm Before the Storm, by @ZahraaRahal, @pascheet, and @humam_kadara.
https://t.co/felx0ishKu
@MDAndersonNews

[Nature Portfolio @NaturePortfolio]

A paper in @NatureCancer presents PERCEPTION, a precision oncology computational pipeline that can predict the response and resistance of patients by analyzing single-cell transcriptomic data from their tumor samples. 🔒 https://t.co/cFxRB2I6iz

[PhD Voice - Independently Run @PhDVoice]

To help prospective PhD students, what are some red flags to watch out for when looking for a supervisor?

And, what are some green flags?

#PhDVoice @PostdocVoice

[Christophe Massard @drcmassard]

@FerMosele And so pround and lucky to work with a dream team UNLOCK-ICARUS to better understand new drugs to improve the outcome of patients with cancer @y_loriot @FerMosele @Yules86 @FAndreMD @BarbaraPistill2 @GustaveRoussy

[soria @jsoriamd]

A great overview of the clinical ADC landscape with a focus on target, payload mechanism of action, antibody, linker & conjugation method. https://t.co/5t6zTCzgog

[Adrien Mouren, MD @AMourenMD]

Excited to announce I’ve been accepted into the #MCCR Workshop for Young Investigators! 🎉 Organized by @EORTC, @myESMO, & @AACR, it educates on clinical trial design. Thanks Prof. Caroline Robert & @drcmassard for encouragement & support! #OncologyResearch #ClinicalTrials